Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey.
Quirke-McFarlane S, Weinman J, Cook ES, Yiu ZZN, Dand N, Langan SM, Bechman K, Tsakok T, Mason KJ, McAteer H, Meynell F, Coker B, Vincent A, Urmston D, Vesty A, Kelly J, Lancelot C, Moorhead L, Barbosa IA, Bachelez H, Capon F, Contreras CR, De La Cruz C, Di Meglio P, Gisondi P, Jullien D, Lambert J, Naldi L, Puig L, Spuls P, Torres T, Warren RB, Waweru H, Galloway JB, Griffiths CEM, Barker JN, Norton S, Smith CH, Mahil SK; PsoProtect study group. Quirke-McFarlane S, et al. Among authors: naldi l. Br J Dermatol. 2023 Apr 20;188(5):610-617. doi: 10.1093/bjd/ljac144. Br J Dermatol. 2023. PMID: 36763806
Variables associated with joint involvement and development of a prediction rule for arthritis in patients with psoriasis. An analysis of the Italian PsoReal database.
Heidemeyer K, Cazzaniga S, Dondi L, Ronconi G, Pedrini A, Bellatreccia A, Zhong Y, Martini N, Naldi L. Heidemeyer K, et al. Among authors: naldi l. J Am Acad Dermatol. 2023 Jul;89(1):53-61. doi: 10.1016/j.jaad.2023.02.059. Epub 2023 Mar 23. J Am Acad Dermatol. 2023. PMID: 36965671 Free article.
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study).
Augustin M, Sommer R, Daudén E, Laws P, de Jong E, Fabbrocini G, Naldi L, Navarini A, Lambert J, Reguiai Z, Gerdes S, Massana E, Obis T, Kasujee I, Mrowietz U. Augustin M, et al. Among authors: naldi l. BMJ Open. 2023 Feb 15;13(2):e060536. doi: 10.1136/bmjopen-2021-060536. BMJ Open. 2023. PMID: 36792337 Free PMC article.
Lasers for the treatment of psoriasis: a systematic review.
Heidemeyer K, Kulac M, Sechi A, Cazzaniga S, Naldi L. Heidemeyer K, et al. Among authors: naldi l. Expert Rev Clin Immunol. 2023 Jul-Dec;19(7):717-744. doi: 10.1080/1744666X.2023.2205640. Epub 2023 Apr 28. Expert Rev Clin Immunol. 2023. PMID: 37079360
Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.
Brüggen MC, Walsh S, Ameri MM, Anasiewicz N, Maverakis E, French LE, Ingen-Housz-Oro S; DRESS Delphi consensus group; Abe R, Ardern-Jones M, Assier H, Barbaud A, Bensaid B, Bernal W, Bernier C, Brassard A, Brezinová E, Cabañas R, Cardones A, Chu CY, Chua SL, Descamps V, Didona B, Divito SJ, Dodiuk-Gad R, Elman S, Gaspar K, Mortz CG, Hama N, Lee HY, Horváth B, Jörg L, Kaffenberger BH, Kucinskiene V, Lebrun-Vignes B, Lehloenya RJ, Meyersburg D, Micheletti R, Milpied B, Miyagawa F, Mostaghimi A, Nägeli M, Naldi L, Oppel E, Phillips EJ, Pirani T, Ranki A, Mälkönen T, Rosenbach M, Salavastru C, Staumont-Salle D, Sandberg H, Setterfield J, Shinkai K, Shiohara T, Soria A, Tartar D, Tiplica GS, Traidl S, Vorobyev A, von Wachter C, Worswick S, Cho YT. Brüggen MC, et al. Among authors: naldi l. JAMA Dermatol. 2024 Jan 1;160(1):37-44. doi: 10.1001/jamadermatol.2023.4450. JAMA Dermatol. 2024. PMID: 37966824
Vitiligo: Epidemiology and Economic Impact.
Naldi L, Pagani A, Alduini C. Naldi L, et al. Dermatol Pract Concept. 2023 Dec 1;13(4S2):e2023315S. doi: 10.5826/dpc.1304S2a315S. Dermatol Pract Concept. 2023. PMID: 38241395 Free PMC article. Review.
Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study.
Gnesotto L, Mioso G, Bardazzi F, Filippi F, Di Lernia V, Motolese A, Di Nuzzo S, Conti A, Arginelli F, Corazza M, Odorici G, Borghi A, Gisondi P, Naldi L, Dapavo P, Parodi A, Burlando M, Piaserico S. Gnesotto L, et al. Among authors: naldi l. Acta Derm Venereol. 2023 Mar 28;103:adv4526. doi: 10.2340/actadv.v103.4526. Acta Derm Venereol. 2023. PMID: 36987538 Free PMC article. No abstract available.
Phenotypes of Psoriasis in Patients in Need of Systemic Treatment, and Correlation with Personal Habits, Treatment History and Comorbidities: A Cross-sectional Latent Class Analysis of Data from the Italian PsoReal Registry.
Cazzaniga S, Heidemeyer K, Naldi L; PsoReal study group. Cazzaniga S, et al. Among authors: naldi l. Acta Derm Venereol. 2023 Apr 4;103:adv5331. doi: 10.2340/actadv.v103.5331. Acta Derm Venereol. 2023. PMID: 37014266 Free PMC article. No abstract available.
497 results